Weight Loss

Can Ozempic trigger depression or suicidal thoughts? Australia weighs in

Australia has issued a safety alert on GLP-1 drugs after reviewing reports of depression and suicidal thoughts; while there is no proven causal link, regulators want users to stay alert

WHO calls for 'responsible use' of GLP-1 drugs for long term obesity care

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural support rather than relying on medication alone

Good old kalonji may help control fat and cholesterol, says new study

A new clinical trial shows that kalonji, long used in Indian kitchens, may help lower cholesterol and slow fat formation, offering a natural metabolic boost alongside regular diet and lifestyle habits

Rising demand for GLP-1 weight-loss drugs reshaping diagnostics market

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

Can weight-loss drugs like Ozempic help reduce alcohol and drug cravings?

Research suggests GLP-1 injections like Ozempic and Zepbound may dampen alcohol and drug cravings by lowering dopamine reward responses, but larger human trials are still underway

Why alcohol may hit harder for people on GLP-1 drugs like Ozempic, Wegovy

A Yale study suggests GLP-1 drugs like semaglutide slow alcohol breakdown in the liver, raising blood alcohol levels even as they reduce toxic byproducts linked to inflammation and liver damage

Novo sticks to oral semaglutide amid rising demand for injectables

Novo Nordisk will strengthen its oral semaglutide portfolio led by Rybelsus while cutting Wegovy injection prices by up to 37% to improve accessibility and expand its market in India

Ten diabetes-friendly grains to steady blood sugar and support weight loss

World Diabetes Day 2025: Experts say shifting from high-GI staples to low-GI grains can help steady blood sugar, curb cravings, improve satiety, and support weight control with simple grain rotation

Novo Nordisk cuts weight-loss drug Wegovy prices by up to 37% in India

Move comes in a bid to gain more space in India's anti-obesity market dominated by Mounjaro

Why losing weight is harder than we think, and how evolution has shaped it

Advances in obesity and metabolism research may mean that future therapies can be able to turn down these signals that drive the body back to its original weight, even beyond the treatment period

Novo Nordisk, Emcure Pharma to launch weight-loss drug under new brand

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk's reach is limited

Russian teens turn to Molecule, a banned pill with deadly weight-loss risks

Marketed as a herbal weight-loss supplement, Molecule has gone viral on Russian TikTok but contains a banned drug linked to heart attacks, anxiety, and hospitalisations among teenagers

Weight-gain woes after the festive cheer? Here's how to bounce-back

From balanced home meals to fun, everyday activities, here's how you can ease back into fitness and lose festive weight sustainably.

New study links weight loss drugs to better liver health outcomes

A new review highlights how anti-obesity drugs like semaglutide and tirzepatide may help reverse fat build-up, inflammation, and scarring in patients with MASLD and MASH

India to get Novo Nordisk's Ozempic soon as demand for obesity drugs surges

Novo Nordisk's Ozempic launch adds to its GLP-1 portfolio, offering patients new options while competing with Eli Lilly's Mounjaro in India

'Fat but fit': New study finds being underweight deadlier than overweight

Those at the lower end of the "healthy" range also faced higher risks, with BMIs between 18.5 and 19.9 doubling the likelihood of death

After Mounjaro success, Eli Lilly plans to launch weight-loss pill in India

Unlike injectable Mounjaro, which focuses on patients with a BMI above 35, Orforglipron is designed for the larger group of patients with a BMI of 27-34, offering an expected weight reduction of 12-16

Are superfoods really healthy? Doctors bust popular wellness myths

Superfoods may boost your diet, but they are no cure-alls. Doctors explain why balance, variety, and local produce matter more than chasing the latest wellness fads

Semaglutide, used in Ozempic, joins WHO's essential medicines list

From cancer drugs to diabetes therapies, WHO's new list expands access to modern medicines and boosts the push for global healthcare equity

Scientists test 4-in-1 drug that may rival Ozempic and bariatric surgery

Researchers explore next-gen obesity drug targeting four hormones at once to overcome limits of existing treatments